Related references
Note: Only part of the references are listed.Proteasome Inhibitors for the Treatment of Multiple Myeloma
Shigeki Ito
CANCERS (2020)
Features of the Proteasome Pool in Spontaneously Occurring Malignant Tumors of the Mammary Gland in Mice
T. M. Astakhova et al.
RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY (2020)
Proteasome Expression in Ovarian Heterotopic Allografts of Wistar and August Rats under Induction of Donor-Specific Tolerance
T. M. Astakhova et al.
RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY (2019)
New proteasome inhibitors in the treatment of multiple myeloma
Vania Tietsche de Moraes Hungria et al.
HEMATOLOGY TRANSFUSION AND CELL THERAPY (2019)
Combined Effect of Bortezomib and Menadione Sodium Bisulfite on Proteasomes of Tumor Cells: The Dramatic Decrease of Bortezomib Toxicity in a Preclinical Trial
Tatiana M. Astakhova et al.
CANCERS (2018)
Regulation of Protein Degradation by Proteasomes in Cancer
Ho Hee Jang
JOURNAL OF CANCER PREVENTION (2018)
PSMB8 as a Candidate Marker of Responsiveness to Preoperative Radiation Therapy in Rectal Cancer Patients
Ye Jin Ha et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11
Jing Li et al.
NATURE CHEMICAL BIOLOGY (2017)
Detection of active proteasome structures in brain extracts: proteasome features of August rat brain with violations in monoamine metabolism
Pavel A. Erokhov et al.
ONCOTARGET (2017)
Effect of Neoadjuvant Chemoradiation Therapy on Proteasome Pool in Rectal Cancer
T. M. Astakhova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Mammalian proteasome subtypes: Their diversity in structure and function
Burkhardt Dahlmann
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)
Targeting the 19S proteasomal subunit, Rpt4, for the treatment of colon cancer
Karen Boland et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways
Rachel Raynes et al.
MOLECULAR ASPECTS OF MEDICINE (2016)
The Expression and Clinical Significance of PA28 γ in Colorectal Cancer
Debo Chen et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
A Reversible and Highly Selective Inhibitor of the Proteasomal Ubiquitin Receptor Rpn13 Is Toxic to Multiple Myeloma Cells
Darci J. Trader et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
PA28αβ Reduces Size and Increases Hydrophilicity of 20S Immunoproteasome Peptide Products
Mary Raule et al.
CHEMISTRY & BIOLOGY (2014)
Proteasome Functioning in Breast Cancer: Connection with Clinical-Pathological Factors
Elena E. Shashova et al.
PLOS ONE (2014)
Pattern of MHC class I and immune proteasome expression in Walker 256 tumor during growth and regression in Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis
Liudmila A. Zakharova et al.
CELLULAR IMMUNOLOGY (2011)
Changes in proteasome pool in human papillary thyroid carcinoma development
Natalia P. Sharova et al.
CENTRAL EUROPEAN JOURNAL OF BIOLOGY (2011)
Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules
Benoit Guillaume et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Changes in the Proteasome Pool during Malignant Transformation of Mouse Liver Cells
T. M. Astakhova et al.
ACTA NATURAE (2010)
The proteasome: Overview of structure and functions
Keiji Tanaka
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics
Shishan Deng et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Multiple forms of proteasomes and approaches to their separation
EB Abramova et al.
BIOLOGY BULLETIN (2004)
The structure of the mammalian 20S proteasome at 2.75 Å resolution
M Unno et al.
STRUCTURE (2002)